A.OostraA
Have no history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2
Sharma AK, Roberts RL, Benson RD et al (2020) The senolytic drug navitoclax (ABT-263) causes trabecular bone loss and impaired osteoprogenitor function in aged mice
H tr lm sng v ci thin tnh trng da xn mu Gip lm u mu da, ci thin cc vn thm sm H tr thu nh l chn lng, kim sot b nhn v gip b mt da trng mn mng hn Tng cng kh nng chng oxy ha, h tr lm chm qu trnh lo ha da Cung cp m nh, hn ch tnh trng kh cng sau khi lm sch Bng thnh phn sn phm Water, Dipropylene Glycol, Caprylic/Capric Triglyceride, Niacinamide, Cetyl Ethylhexanoate, 1,2-Hexanediol, Squalane, Dimethicone, Glutathione, Cetearyl Olivate, Polysorbate 20, Phenoxyethanol, Sorbitan Olivate, Cetearyl Alcohol, Triethanolamine, Carbomer, Tocopheryl Acetate, Adenosine, Glycerin, Butylene Glycol, C13-14 Isoparaffin, Xanthan Gum, Disodium EDTA, Oryza Sativa (Rice) Bran Extract, Milk Protein Extract, Punica Granatum Fruit Extract, Cornus Officinalis Fruit Extract, Rosa Damascena Flower Extract, Pulsatilla Koreana Extract, Hippophae Rhamnoides Fruit Extract, Rosa Canina Fruit Extract, Zanthoxylum Piperitum Fruit Extract, Usnea Barbata (Lichen) Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Laureth-7, Centella Asiatica Extract, Glyceryl Acrylate/Acrylic Acid Copolymer, Fragrance, Ethylhexylglycerin, Kojyl Carboxy Dipeptide-23, Caprylyl Glycol
